The blood-collection technology developed by emerging medtech firm Tasso Inc. has broad appeal.
Not only do the device’s design and upper-arm placement reportedly cause far less pain than traditional blood draws, but it...
MDSAP Audit Allows Emerging Firm To Expand Internationally
Blood-collection technology firm Tasso has been recommended for certification by MDSAP. The international qualification is part of a push to offer the company’s technology in countries such as Australia and Canada, CEO Ben Casavant told Medtech Insight.